In a rare trial at the University of Oxford former covid patients will be reinfected to extract the information on effective vaccines to counter the pathogen. Oxford researchers will study these previously infected people under controlled, quarantined conditions for at least 17 days.

Oxford researchers launch human challenge trial to study Covid reinfection

human-challenge-trial

Human Challenge Trial, News on Human Challenge Trial, stories on Human Challenge Trial, articles on Human Challenge Trial, Human Challenge Trial stories at Wion, Human Challenge Trial news, Human Challenge Trial latest news

human challenge-trial

Oxford researchers launch human challenge trial to study Covid reinfection